GRAIL, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
GRAIL, Inc. (GRAL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.00 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 4.00M shares, a 27.38% decline year-over-year.
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 5.85M shares, a 5.00% decline year-over-year.
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 5.32M shares, a 25.20% increase year-over-year.
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 5.51M shares, a 17.36% decline year-over-year.
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 5.04M shares, a 10.41% decline from fiscal 2024.
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.63M shares, a 15.61% decline from fiscal 2023.
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.67M shares, a 0.00% change from fiscal 2023.
- GRAIL, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.67M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.00M shares 10-Q · filed 2026-08-06 | 4.00M shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 5.85M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 5.04M shares 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | 5.32M shares 10-Q · filed 2025-11-13 | 5.32M shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 5.51M shares 10-Q · filed 2026-08-06 | 5.51M shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 6.16M shares 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | 5.63M shares 10-K · filed 2026-03-12 | 2.78M shares 10-K · filed 2025-03-05 | ||||||
| 2024-09-30 | 4.25M shares 10-Q · filed 2025-11-13 | 4.30M shares 10-Q · filed 2024-11-13 | 4.25M shares 10-Q · filed 2025-11-13 | 4.30M shares 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | 6.67M shares 10-Q · filed 2025-08-13 | 6.70M shares 10-Q · filed 2024-08-13 | 6.67M shares 10-Q · filed 2025-08-13 | 6.70M shares 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | 104.31K shares 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | 6.67M shares 10-K · filed 2025-03-05 | |||||||
| 2023-10-01 | 6.70M shares 10-Q · filed 2024-11-13 | 6.70M shares 10-Q · filed 2024-11-13 | ||||||
| 2023-01-01 | 6.67M shares 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |